Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

HAART Chart: Approved Antiretroviral Drugs

Summer 2007

Generic (Common) NameBrand NameCompanyYear Approved
Protease Inhibitors (PIs)
amprenavirAgeneraseGlaxoSmithKline1999; discontinued 2004
atazanavirReyatazBristol-Myers Squibb2003
darunavir (TMC114) PrezistaTibotec2006
fosamprenavirLexiva (U.S.); Telzir (Europe)GlaxoSmithKline2003
indinavirCrixivanMerck1996
lopinavir/ritonavirKaletraAbbott2000; Meltrex formulation 2005
nelfinavirViraceptPfizer1997
ritonavirNorvirAbbott1996
saquinavirInvirase (hard-gel)
Fortovase (soft-gel)
Roche1995
1997; withdrawn 2005
tipranavirAptivusBoehringer Ingelheim2005
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
abacavirZiagenGlaxoSmithKline1998
didanosine (ddI)VidexBristol-Myers Squibb1989; extended release Videx EC 2000
emtricitabine (FTC)EmtrivaGilead2003
lamivudine (3TC)EpivirGlaxoSmithKline1995
stavudine (d4T)ZeritBristol-Myers Squibb1994
tenofovir DFVireadGilead2002
zalcitabine (ddC)HividRoche1992; withdrawn 2005
zidovudine (AZT)RetrovirGlaxoSmithKline1987
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
delavirdineRescriptorPfizer1997
efavirenzSustiva (U.S.); Stocrin (elsewhere)Bristol-Myers Squibb1998
nevirapineViramuneBoehringer Ingelheim1996
Entry/Fusion Inhibitors
enfuvirtide (T-20)FuzeonTrimeris2003
Fixed-Dose Combinations
lamivudine/abacavir (NRTI)Epzicom (U.S.); Kivexa (Europe)GlaxoSmithKline2004
tenofovir/emtricitabine (NRTI)TruvadaGilead2004
tenofovir/emtricitabine/
efavirenz (NRTI/NNRTI)
AtriplaGilead/Bristol-Myers Squibb2006
zidovudine/lamivudine (NRTI)CombivirGlaxoSmithKline1997
zidovudine/lamivudine/abacavir (NRTI)TrizivirGlaxoSmithKline2000





  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS. Visit San Francisco AIDS Foundation's Web site to find out more about their activities, publications and services.
 

Tools
 

Advertisement